Development and applications of a monoclonal antibody to a recombinant beak and feather disease virus (BFDV) capsid protein.

P.L. Shearer, N. Bonne, P. Clark, Margaret Sharp, Shane Raidal

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The development of diagnostic assays for detecting beak and feather disease virus (BFDV) has traditionally been hampered by the difficulty associated with producing suitable reagents, namely purified virus and polyclonal antibodies. In an effort to develop a consistent and standardised source of antibody, a monoclonal antibody to a recombinant BFDV capsid protein has been developed and its use in western blotting, immunohistochemistry (IHC), ELISA and haemagglutination-inhibition (HI) assays characterised. The antibody was specific for both the recombinant BFDV capsid protein and the whole virus and had similar optimal titres when used in western blotting and IHC. The antibody also had HI activity and detected BFDV virus from three genera of psittacine birds, including the recently described cockatiel BFDV isolate. The monoclonal antibody should have widespread application in both research and the development of diagnostic assays for BFDV.
Original languageEnglish
Pages (from-to)206-212
Number of pages7
JournalJournal of Virological Methods
Volume147
Issue number2
DOIs
Publication statusPublished - 2008

Fingerprint Dive into the research topics of 'Development and applications of a monoclonal antibody to a recombinant beak and feather disease virus (BFDV) capsid protein.'. Together they form a unique fingerprint.

  • Cite this